Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/Sales ratio high or low?
The EV/Sales ratio of 5.67x is in line with its estimated 5-year average of 5.58x, around the middle of its estimated 5-year range (4.15x–7.03x).
As of 2026-09-10T20:00:02.000Z. 6.87% above its estimated 12-month average of 5.31x.
Quote observation: 2026-09-10T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 8233e5283909ab17bac4fe0d43cc0ba3aba61090fff26db7a4ef3d6a4b71faa0
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
5.67x
EV/SALES RATIO AVG TTM
5.31x
EV/SALES RATIO AVG 3Y
5.37x
EV/SALES RATIO AVG 5Y
5.58x
EV/SALES RATIO AVG 10Y
5.45x
EV/SALES RATIO AVG 15Y
4.77x
EV/SALES RATIO AVG 20Y
4.21x
CURRENT VS TTM AVG
+6.87%
CURRENT VS 3Y AVG
+5.67%
CURRENT VS 5Y AVG
+1.53%
CURRENT VS 10Y AVG
+4.13%
CURRENT VS 15Y AVG
+18.92%
CURRENT VS 20Y AVG
+34.64%
SECTOR MEDIAN · HEALTHCARE
3.63x
median of 87 covered companies
CURRENT VS SECTOR MEDIAN
+56.20%
vs the sector median at left
Thermo Fisher Scientific Inc.
Market Cap
$224.15B
EV/Sales Ratio
5.67x
TTM Avg
5.31x
3Y Avg
5.37x
5Y Avg
5.58x
Market Cap
$179.79B
EV/Sales Ratio
6.66x
TTM Avg
6.19x
3Y Avg
5.14x
5Y Avg
4.73x
Market Cap
$130.60B
EV/Sales Ratio
10.01x
TTM Avg
9.52x
3Y Avg
10.11x
5Y Avg
9.22x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc. (TMO) | $224.15B | 5.67x | 5.31x | 5.37x | 5.58x |
| Amgen Inc. (AMGN)vs › | $206.42B | 6.55x | 6.40x | 6.60x | 6.40x |
| AstraZeneca PLC (AZN)vs › | $247.58B | 4.48x | 5.19x | 5.07x | 5.23x |
| Novo Nordisk A/S (NVO)vs › | $195.43B | 4.11x | 4.73x | 9.91x | 10.69x |
| Gilead Sciences, Inc. (GILD)vs › | $179.79B | 6.66x | 6.19x | 5.14x | 4.73x |
| Abbott Laboratories (ABT)vs › | $178.87B | 4.43x | 4.68x | 4.98x | 4.91x |
| Pfizer Inc. (PFE)vs › | $157.59B | 3.45x | 3.33x | 3.49x | 3.53x |
| Danaher Corporation (DHR)vs › | $141.00B | 6.50x | 6.55x | 7.17x | 6.92x |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $130.60B | 10.01x | 9.52x | 10.11x | 9.22x |
| Bristol-Myers Squibb Company (BMY)vs › | $130.22B | 3.35x | 3.11x | 3.10x | 3.43x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2026-09-09 | 5.68x |
| 2026-09-08 | 5.66x |
| 2026-09-04 | 5.74x |
| 2026-09-03 | 5.78x |
| 2026-09-02 | 5.70x |
| 2026-09-01 | 5.64x |
| 2026-08-31 | 5.77x |
| 2026-08-28 | 5.81x |
| 2026-08-27 | 5.88x |
| 2026-08-26 | 5.90x |
| 2026-08-25 | 5.86x |
| 2026-08-24 | 5.86x |
| 2026-08-21 | 5.87x |
| 2026-08-20 | 5.86x |
| 2026-08-19 | 5.74x |
| 2026-08-18 | 5.55x |
| 2026-08-17 | 5.52x |
| 2026-08-14 | 5.54x |
| 2026-08-13 | 5.60x |
| 2026-08-12 | 5.66x |
| 2026-08-11 | 5.67x |
| 2026-08-10 | 5.63x |
| 2026-08-07 | 5.59x |
| 2026-08-06 | 5.47x |
| 2026-08-05 | 5.46x |
| 2026-08-04 | 5.35x |
| 2026-08-03 | 5.43x |
| 2026-07-31 | 5.62x |
| 2026-07-30 | 5.64x |
| 2026-07-29 | 5.64x |
| 2026-07-28 | 5.64x |
| 2026-07-27 | 5.50x |
| 2026-07-24 | 5.57x |
| 2026-07-23 | 5.61x |
| 2026-07-22 | 5.23x |
| 2026-07-21 | 5.20x |
| 2026-07-20 | 5.23x |
| 2026-07-17 | 5.28x |
| 2026-07-16 | 5.37x |
| 2026-07-15 | 5.30x |
| 2026-07-14 | 5.29x |
| 2026-07-13 | 5.24x |
| 2026-07-10 | 5.23x |
| 2026-07-09 | 5.21x |
| 2026-07-08 | 5.09x |
| 2026-07-07 | 5.15x |
| 2026-07-06 | 5.15x |
| 2026-07-02 | 5.20x |
| 2026-07-01 | 5.12x |
| 2026-06-30 | 5.02x |
| 2026-06-29 | 5.06x |
| 2026-06-26 | 5.12x |
| 2026-06-25 | 5.06x |
| 2026-06-24 | 4.94x |
| 2026-06-23 | 4.76x |
| 2026-06-22 | 4.71x |
| 2026-06-18 | 4.72x |
| 2026-06-17 | 4.69x |
| 2026-06-16 | 4.78x |
| 2026-06-15 | 4.79x |
| 2026-06-12 | 4.76x |
| 2026-06-11 | 4.81x |
| 2026-06-10 | 4.86x |
| 2026-06-09 | 4.96x |
| 2026-06-08 | 4.76x |
| 2026-06-05 | 4.78x |
| 2026-06-04 | 4.86x |
| 2026-06-03 | 4.79x |
| 2026-06-02 | 4.86x |
| 2026-06-01 | 4.96x |
| 2026-05-29 | 4.95x |
| 2026-05-28 | 4.90x |
| 2026-05-27 | 4.65x |
| 2026-05-26 | 4.58x |
| 2026-05-22 | 4.58x |
| 2026-05-21 | 4.59x |
| 2026-05-20 | 4.61x |
| 2026-05-19 | 4.58x |
| 2026-05-18 | 4.53x |
| 2026-05-15 | 4.50x |
| 2026-05-14 | 4.58x |
| 2026-05-13 | 4.56x |
| 2026-05-12 | 4.67x |
| 2026-05-11 | 4.62x |
| 2026-05-08 | 4.72x |
| 2026-05-07 | 4.80x |
| 2026-05-06 | 4.79x |
| 2026-05-05 | 4.74x |
| 2026-05-04 | 4.70x |
| 2026-05-01 | 4.63x |
| 2026-04-30 | 4.72x |
| 2026-04-29 | 4.61x |
| 2026-04-28 | 4.64x |
| 2026-04-27 | 4.62x |
| 2026-04-24 | 4.64x |
| 2026-04-23 | 4.61x |
| 2026-04-22 | 5.01x |
| 2026-04-21 | 5.10x |
| 2026-04-20 | 5.11x |
| 2026-04-17 | 5.12x |
| 2026-04-16 | 5.03x |
| 2026-04-15 | 5.16x |
| 2026-04-14 | 5.12x |
| 2026-04-13 | 5.01x |
| 2026-04-10 | 4.86x |
| 2026-04-09 | 4.90x |
| 2026-04-08 | 4.92x |
| 2026-04-07 | 4.80x |
| 2026-04-06 | 4.79x |
| 2026-04-02 | 4.82x |
| 2026-04-01 | 4.85x |
| 2026-03-31 | 4.82x |
| 2026-03-30 | 4.72x |
| 2026-03-27 | 4.67x |
| 2026-03-26 | 4.80x |
| 2026-03-25 | 4.82x |
| 2026-03-24 | 4.81x |
| 2026-03-23 | 4.71x |
| 2026-03-20 | 4.68x |
| 2026-03-19 | 4.64x |
| 2026-03-18 | 4.59x |
| 2026-03-17 | 4.66x |
| 2026-03-16 | 4.64x |
| 2026-03-13 | 4.59x |
| 2026-03-12 | 4.69x |
| 2026-03-11 | 4.86x |
| 2026-03-10 | 4.89x |
| 2026-03-09 | 4.98x |
| 2026-03-06 | 4.91x |
| 2026-03-05 | 5.05x |
| 2026-03-04 | 5.00x |
| 2026-03-03 | 4.96x |
| 2026-03-02 | 4.97x |
| 2026-02-27 | 5.07x |
| 2026-02-26 | 5.27x |
| 2026-02-25 | 5.21x |
| 2026-02-24 | 5.23x |
| 2026-02-23 | 5.23x |
| 2026-02-20 | 5.19x |
| 2026-02-19 | 5.22x |
| 2026-02-18 | 5.21x |
| 2026-02-17 | 5.11x |
| 2026-02-13 | 5.13x |
| 2026-02-12 | 5.18x |
| 2026-02-11 | 5.33x |
| 2026-02-10 | 5.44x |
| 2026-02-09 | 5.50x |
| 2026-02-06 | 5.46x |
| 2026-02-05 | 5.46x |
| 2026-02-04 | 5.66x |
| 2026-02-03 | 5.70x |
| 2026-02-02 | 5.80x |
| 2026-01-30 | 5.77x |
| 2026-01-29 | 5.89x |
| 2026-01-28 | 6.03x |
| 2026-01-27 | 6.16x |
| 2026-01-26 | 6.19x |
| 2026-01-23 | 6.18x |
| 2026-01-22 | 6.30x |
| 2026-01-21 | 6.27x |
| 2026-01-20 | 6.12x |
| 2026-01-16 | 6.12x |
| 2026-01-15 | 6.17x |
| 2026-01-14 | 6.14x |
| 2026-01-13 | 6.02x |
| 2026-01-12 | 6.09x |
| 2026-01-09 | 6.12x |
| 2026-01-08 | 6.01x |
| 2026-01-07 | 6.10x |
| 2026-01-06 | 6.14x |
| 2026-01-05 | 6.05x |
| 2026-01-02 | 5.89x |
| 2025-12-31 | 5.78x |
| 2025-12-30 | 5.81x |
| 2025-12-29 | 5.83x |
| 2025-12-26 | 5.79x |
| 2025-12-24 | 5.78x |
| 2025-12-23 | 5.78x |
| 2025-12-22 | 5.75x |
| 2025-12-19 | 5.68x |
| 2025-12-18 | 5.63x |
| 2025-12-17 | 5.63x |
| 2025-12-16 | 5.70x |
| 2025-12-15 | 5.75x |
| 2025-12-12 | 5.72x |
| 2025-12-11 | 5.77x |
| 2025-12-10 | 5.73x |
| 2025-12-09 | 5.64x |
| 2025-12-08 | 5.68x |
| 2025-12-05 | 5.72x |
| 2025-12-04 | 5.74x |
| 2025-12-03 | 5.79x |
| 2025-12-02 | 5.79x |
| 2025-12-01 | 5.83x |
| 2025-11-28 | 5.88x |
| 2025-11-26 | 5.90x |
| 2025-11-25 | 5.94x |
| 2025-11-24 | 5.84x |
| 2025-11-21 | 5.85x |
| 2025-11-20 | 5.72x |
| 2025-11-19 | 5.73x |
| 2025-11-18 | 5.75x |
| 2025-11-17 | 5.67x |
| 2025-11-14 | 5.77x |
| 2025-11-13 | 5.78x |
| 2025-11-12 | 5.85x |
| 2025-11-11 | 5.84x |
| 2025-11-10 | 5.75x |
| 2025-11-07 | 5.72x |
| 2025-11-06 | 5.66x |
| 2025-11-05 | 5.68x |
| 2025-11-04 | 5.66x |
| 2025-11-03 | 5.65x |
| 2025-10-31 | 5.67x |
| 2025-10-30 | 5.57x |
| 2025-10-29 | 5.59x |
| 2025-10-28 | 5.59x |
| 2025-10-27 | 5.64x |
| 2025-10-24 | 5.72x |
| 2025-10-23 | 5.71x |
| 2025-10-22 | 5.67x |
| 2025-10-21 | 5.59x |
| 2025-10-20 | 5.47x |
| 2025-10-17 | 5.42x |
| 2025-10-16 | 5.40x |
| 2025-10-15 | 5.33x |
| 2025-10-14 | 5.31x |
| 2025-10-13 | 5.30x |
| 2025-10-10 | 5.30x |
| 2025-10-09 | 5.39x |
| 2025-10-08 | 5.40x |
| 2025-10-07 | 5.43x |
| 2025-10-06 | 5.47x |
| 2025-10-03 | 5.46x |
| 2025-10-02 | 5.30x |
| 2025-10-01 | 5.35x |
| 2025-09-30 | 4.95x |
| 2025-09-29 | 4.75x |
| 2025-09-26 | 4.77x |
| 2025-09-25 | 4.73x |
| 2025-09-24 | 4.80x |
| 2025-09-23 | 4.82x |
| 2025-09-22 | 4.86x |
| 2025-09-19 | 4.90x |
| 2025-09-18 | 4.92x |
| 2025-09-17 | 4.84x |
| 2025-09-16 | 4.91x |
| 2025-09-15 | 4.86x |
| 2025-09-12 | 4.90x |
| 2025-09-11 | 5.01x |
| 2025-09-10 | 4.88x |
| 2025-09-09 | 4.93x |
| 2025-09-08 | 4.98x |
| 2025-09-05 | 5.02x |
| 2025-09-04 | 4.99x |
| 2025-09-03 | 4.95x |
| 2025-09-02 | 4.97x |
| 2025-08-29 | 5.02x |
| 2025-08-28 | 4.99x |
| 2025-08-27 | 4.98x |
Showing the most recent 260 of 5,030 data points. The chart above shows the full history.
